Bosnia and Herzegovina vs El Salvador: Deaths from Alzheimer's
Bosnia and Herzegovina
1,267 deaths
in 2021
El Salvador
1,318 deaths
in 2021
Bosnia and Herzegovina rank
82nd
El Salvador rank
80th
Deaths from Alzheimer's over time
- Bosnia and Herzegovina
- El Salvador
How they compare
El Salvador currently reports 1,318 deaths against 1,267 deaths in Bosnia and Herzegovina, a difference of 51 deaths.
The two have swapped places 9 times across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 82nd and El Salvador ranks 80th of 194 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 1 and El Salvador in 2.
Head to head by decade
| Decade | Bosnia and Herzegovina | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 800.76 deaths | 797.67 deaths | 3.09 deaths | Bosnia and Herzegovina |
| 2010s | 1,056 deaths | 1,122 deaths | 65.13 deaths | El Salvador |
| 2020s | 1,248 deaths | 1,346 deaths | 97.68 deaths | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from alzheimer's, Bosnia and Herzegovina or El Salvador?
- El Salvador, at 1,318 deaths against 1,267 deaths in Bosnia and Herzegovina as of 2021.
- What is the difference in deaths from alzheimer's between Bosnia and Herzegovina and El Salvador?
- 51 deaths, with El Salvador ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and El Salvador?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and El Salvador rank globally for deaths from alzheimer's?
- Bosnia and Herzegovina ranks 82nd and El Salvador ranks 80th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes.